Skip to content
10-K

Annual Report

GUIDED THERAPEUTICS INC GTHP

0001477932-25-002200

← back to feed
Filed
Mar 31, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 18, 2025 77.97M sh
Stock Issued FY 2024 · Dec 31, 2024 11.03M sh
Stock Issued FY 2024 · Dec 31, 2023 5.51M sh
Shares Diluted FY 2024 · Dec 31, 2023 51.13M sh
Operating Cash Flow FY 2024 · Dec 31, 2023 −$1.75M
Current Liabilities FY 2024 · Dec 31, 2023 $4.81M
Total Liabilities FY 2024 · Dec 31, 2023 $5.48M
Current Assets FY 2024 · Dec 31, 2023 $1.39M
Total Assets FY 2024 · Dec 31, 2023 $1.67M
Eps Diluted FY 2024 · Dec 31, 2023 −$0.07
Eps Basic FY 2024 · Dec 31, 2023 −$0.07
Sga Expense FY 2024 · Dec 31, 2023 $3M
Rd Expense FY 2024 · Dec 31, 2023 $228K
Net Income FY 2024 · Dec 31, 2023 −$3.49M
Operating Income FY 2024 · Dec 31, 2023 −$3.46M
Gross Profit FY 2024 · Dec 31, 2023 $36K
Revenue FY 2024 · Dec 31, 2023 $98K
Stockholders Equity FY 2024 · Dec 31, 2022 −$2.88M